News

White House walks back proposed kratom opioid ban despite safety concerns

By Ella Ruder 1 min read

Federal health officials have proposed loosening a ban on mitragynine pseudoindoxyl, or MGPI, a potent opioid compound found in some kratom products, to allow the substance at certain levels, The New York Times reported Oct. 28. HHS Secretary Robert F. Kennedy Jr. announced the policy shift Oct. 9. The Drug Enforcement Administration said July 1 that it planned to ban MGPI and two other compounds, and the Justice Department announced emergency temporary scheduling of the compounds Aug. 25. The revised policy continues to prohibit highly concentrated MGPI products but would… Originally published in Becker’s Hospital Review. Read More

Share this post

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.